-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q3 2024.
- X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.18 USD/shares, a 1700% decline year-over-year.
- X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.06 USD/shares, a 86.4% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2023 was -0.57 USD/shares, a 62.5% increase from 2022.
- X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2022 was -1.52 USD/shares, a 61.9% increase from 2021.
- X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2021 was -3.99 USD/shares, a 29.1% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)